Chronic obstructive pulmonary disease significantly affects patients' quality of life. The treatment strategy involves both non-pharmacological therapies, including smoking cessation, as well as drug-based therapies. Inhaled bronchodilators are at the heart of the therapy. The pharmacist must encourage compliance. (c) 2017 Elsevier Masson SAS. All rights reserved.